טוען...
Single dose oral ranolazine pharmacokinetics in patients receiving maintenance hemodialysis
Purpose: Ranolazine is a novel anti-angina treatment approved in the United States for chronic stable angina. Ranolazine pharmacokinetics have not been studied previously in patients who receive maintenance hemodialysis. This study describes the pharmacokinetics of ranolazine and three major metabol...
שמור ב:
| הוצא לאור ב: | Ren Fail |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6442103/ https://ncbi.nlm.nih.gov/pubmed/30909832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/0886022X.2019.1585371 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|